Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Avicursen by Percheron Therapeutics for Duchenne Muscular Dystrophy: Likelihood of Approval
Avicursen is under clinical development by Percheron Therapeutics and currently in Phase II for Duchenne Muscular Dystrophy. According to GlobalData,...
Data Insights
Avicursen by Percheron Therapeutics for Relapsing Remitting Multiple Sclerosis (RRMS): Likelihood of Approval
Avicursen is under clinical development by Percheron Therapeutics and currently in Phase II for Relapsing Remitting Multiple Sclerosis (RRMS). According...